Gut Microbiota in Disease—Third Edition
A special issue of Microorganisms (ISSN 2076-2607). This special issue belongs to the section "Gut Microbiota".
Deadline for manuscript submissions: 31 July 2024 | Viewed by 475
Special Issue Editor
Interests: gut microbiota; liver disease; hepatocellular carcinoma; liver cirrhosis; nonalcoholic fatty liver disease
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
This Special Issue is a continuation of our previous Special Issue, “Gut Microbiota in Disease”.
The gut microbiota is composed of trillions of microorganisms that reside in our digestive system and perform a number of essential functions for human health. In fact, it constitutes the variable part of our genetic equipement, can be influenced by multiple factors, including drugs or diet, and contributes to the metabolism of nutrients, bile acids and xenobiotics, modulating the host immune system and systemic inflammatory state, and the proper functioning of the intestinal barrier. Perturbations of the intestinal microbiota may underlie the pathogenesis of numerous disease processes not only in the digestive tract, but also the whole organism. Complex alterations in the composition and function of the gut microbiome, collectively defined as dysbiosis, are a crucial point in the progression of pathologies, such as liver cirrhosis, immune-mediated diseases and neurological disorders. Therefore, modulation of the gut microbiome becomes fundamental to stop the progression of several diseases and regulate the response to therapy in specific contexts, such as in cancer patients who are treated with immunotherapy.
The aim of this Special Issue is to report the latest evidence on the role of the gut microbiome in influencing human health, particularly regarding its contribution to various disease processes, and how its modulation may affect the development and progression of diseases.
Dr. Francesca Romana Ponziani
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Microorganisms is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- gut microbiome
- intestinal barrier
- inflammation
- immune system
- antibiotics
- cancer
